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ABSTRACT 
BACKGROUND:  In a previous tudy, otprinone was found to be more effective than 
milrinone in improving hypercapnic depression of diaphragmatic contractility in dogs. 
OBJECT IVE:  The purpose of this experimental study was to assess the dose- 
related effects of olprinone on hypercapnia-induced impairment of diaphragmatic 
contractility. 
METHODS:  This study was conducted at the Department of Anesthesiology, 
Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan. Hypercapnia 
(partial pressure of carbon dioxide [CO 2] in arterial blood 80-90 mm Hg) was 
induced in pentobarbital-anesthetized dogs by adding 10% CO 2 to their inspired 
gas. When hypercapnia was established, the dogs were randomly assigned to 1 of 
4 groups: (all dogs were administered a bolus dose of olprinone 10 mg/kg) group 
1 was maintained with olprinone 0.1 pg/kg • minq; group 2 was maintained with 
olprinone 0.3 pg/kg • min-1; group 3 was maintained with olprinone 0.5 I~g/kg • 
min-;; and group 4 received no study drug. The study drug was administered IV for 
60 minutes. Diaphragmatic contractility was assessed by transdiaphragmatic pressure 
(Pdi). The study investigator was not blinded to treatment assignment. 
RESULTS:  Twenty-four healthy adult mongrel dogs were used in the study; 
6 dogs were assigned to each treatment group. In the presence of hypercapnia in 
each group, Pdi (mean [SD], cm H20) at low-frequency (20-Hz) and high-frequency 
(100-Hz) stimulation significantly decreased from baseline (all, P = 0.001). During 
study drug administration i  groups 1, 2, and 3, Pdi at both stimuli levels increased 
significantly from hypercapnia-induced values (all, P = 0.001); in group 4, Pdi to 
each stimulus did not change significantly from hypercapnia-induced values. There 
was a significant correlation between olprinone dose and Pdi at both stimuli (all, P = 
0.001). The regression equations were: Pdi at 20-Hz stimulation (cm H20) = 24.97 × 
olprinone dose (l~g/kg • min q) + 13.54 (r = 0.887; n = 24) and Pdi at 100-Hz stimula- 
tion (cm H20) = 29.18 x olprinone dose (pg/kg. min -1) + 20.55 (r = 0.911; n = 24). 
CONCLUSION:  Olprinone was associated with a dose-dependent improve- 
ment of hypercapnia-induced impairment of diaphragmatic contractility in these 
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pentobarbital-anesthetized dogs. (Curt Ther Res Clin Exp. 2008;69:243-251) © 2008 
Excerpta Medica Inc. 
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INTRODUCTION 
The diaphragm is the most important inspiratory muscle in the respiratory pump sys- 
tem. 1 In normal human subjects, hypercapnia is associated with diaphragm muscle 
dysfunction that is a reduction of diaphragmatic force generated for a constant elective 
myographic activity. ~ Aminophylline and neostigmine are effective for improving 
hypercapnic depression of diaphragmatic contractility, but isoproterenol does not affect 
diaphragm muscle dysfunction induced by hypercapnia. 3 
A previous tudy 4of the effects of milrinone and olprinone on hypercapnic depres- 
sion of diaphragmatic contractility in dogs found that olprinone was more effective 
than milrinone in improving hypercapnia-induced impairment of diaphragmatic con- 
tractility. This may have important herapeutic mplication for patients with limited 
respiratory muscle performance, which may contribute to hypoventilation. 4 A litera- 
ture search did not reveal any published study of the relationship between olprinone 
dose and diaphragmatic contractility during hypercapnia. 
This experimental study was undertaken to assess the dose-related effects of 
olprinone on hypercapnia-induced impairment of diaphragmatic contractility in 
pentobarbital-anesthetized dogs. 
MATERIALS  AND METHODS 
This study was conducted at the Department of Anesthesiology, Institute of Clinical 
Medicine, University of Tsukuba, Tsukuba, Japan. The protocol was approved by our 
animal research committee, and animal care was conducted in accordance with guide- 
lines for ethical animal research. 4,5 The lead study investigator (Y.F.) performed all mea- 
surements and analyses in this study and was not blinded to treatment assignment. 
Adult (aged > 5 years) mongrel dogs (provided by Animal Guidance Center, Mashiko, 
Japan) weighing 10 to 15 kg were used in the study. Animals were randomly assigned, 
using a computer-generated random number list, to 1 of 4 treatment groups. 
Animal preparation was similar to that described previously. 4,5 Briefly, anesthesia 
was maintained with IV pentobarbital 2 mg/kg • h -1. This dose had been found to have 
no effect on diaphragmatic contractility. 6 No muscle relaxants were used. Each dog's 
trachea was intubated, and ventilation was mechanically controlled with a mixture of 
oxygen and air (40% inspired oxygen) to maintain arterial partial pressure of oxygen 
(PO~) > 100 mm Hg, arterial partial pressure of carbon dioxide (PCO~) 30 to 40 mm Hg, 
and arterial pH 7.35 to 7.45. The right femoral artery (for monitoring arterial blood 
pressure) and vein (for administering maintenance fluids [lactated Ringer's solution 
10 mg/kg • h -1] and pentobarbital) were cannulated. The left femoral vein was can- 
nulated for administration of the study drug. Rectal temperature was monitored con- 
tinuously and maintained at 36.5°C to 37.5°C using a heating pad. 
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Transdiaphragmatic pressure (Pdi) was measured by means of 2 thin-walled latex 
balloons--one was positioned in the stomach and the other in the middle third 
of the esophagus. Balloons were connected to a differential pressure transducer 
(TP 604T, Nihon Koden, Tokyo,Japan) and amplifier (model 1257, Nihondenki San-ei, 
Tokyo, Japan). Phrenic nerves were bilaterally exposed at the neck, and stimulating 
electrodes were placed around them. Supramaximal e ectrical stimuli (10-15 V) of 
0.1-millisecond uration were applied for 2 seconds at low-frequency (20-Hz) and 
high-frequency (100-Hz) stimulation with an electrical stimulator (SEN-3301, 
Nihon Koden). Diaphragmatic contractility was assessed by measuring the maximal 
Pdi generated by test stimuli after airway occlusion at functional residual capacity. 
Electrical activity of the diaphragm was recorded using 2 pairs of fishhook elec- 
trodes. Activity signals from the diaphragm were rectified and integrated with an 
integrator (type 1322, Nihondenki San-ei) with a time constant of 0.1 second. This 
was regarded as the integrated activity of the crural (Edi-cru) and costal (Edi-cost) 
portions of the diaphragm. 
The dogs were allowed to stabilize after preparation for ->30 minutes before study 
initiation. Baseline measurements of hemodynamic variables (heart rate [HR], mean 
arterial pressure [MAP]), arterial blood gas values (pH, PCO2, PO2) , Pdi, Edi-cru, and 
Edi-cost were recorded in each group. Hypercapnia (PCO 2 80-90 mm Hg) was 
produced by adding 10% CO 2 to the inspired gas. When hypercapnia was established 
at 2 hours after the onset of CO 2 administration, group 1 received olprinone 10 lag/kg 
+ 0.1 pg/kg • min -1 thereafter, group 2 received olprinone 10 pg/kg + 0.3 pg/kg • 
min -1 thereafter, group 3 received olprinone 10 pg/kg + 0.5 pg/kg • min -1 thereafter, 
and group 4 received no study drug. Study drug was continuously administered IV 
for 60 minutes with an infusion pump. After administering the study drug, HR, MAP, 
arterial blood gas values, Pdi, Edi-cru, and Edi-cost were measured. Percentage 
changes from baseline in Edi-cru (%) and Edi-cost (%) were calculated. 4 
STAT IST ICAL  ANALYS IS  
Assuming an o~ of 0.05 and [3 of 0.2, a sample size of 6 dogs in each group would 
be powered to detect a difference in Pdi at 20-Hz and 100-Hz stimulation during 
baseline, hypercapnia, and treatment periods. Values are reported as mean (SD). 
Statistical analyses were performed using analysis of variance for repeated measure- 
ments followed by the Bonferroni-Dunn test for multiple comparisons, paired t test, 
and Student t test, where appropriate. Regression analysis was used to assess the relation- 
ship between olprinone dose and Pdi at both stimuli levels. P < 0.05 was considered 
statistically significant. 
RESULTS 
Twenty-four adult mongrel dogs (14 males and 10 females; mean [SD] weight, 
12.8 [1.4] kg) were included in the study; 6 dogs were assigned to each treatment group. No 
significant differences in baseline hemodynamic variables (HR, MAP), arterial blood gas 
values (pH, PCO2, PO2) , Pdi, Edi-cru (%), or Edi-cost (%) were observed between the 
groups. 
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In the presence of hypercapnia, Pdi at both stimuli significantly decreased from 
baseline in each group (all, P = 0.001). During olprinone administration i  groups 1, 
2, and 3, Pdi at both stimuli significantly increased from hypercapnia-induced values 
(all, P = 0.001). In group 4, Pdi to each stimulus did not change from hypercapnia- 
induced values. No significant changes in Edi-cru (%) and Edi-cost (%) were observed 
throughout the experiment in any group (Table I). 
There was a significant correlation between olprinone dose and Pdi at both stimuli 
(all, P = 0.001). The regression equations were as follows: Pdi at 20-Hz stimulation 
(cm H20) = 24.97 x olprinone dose (lag/kg • min -1) + 13.54 (r = 0.887; n = 24) and 
Pdi at 100-Hz stimulation (cm H20) = 29.18 x olprinone close (lag/kg • min -1) + 
20.55 (r = 0.911; n = 24) (Figure). 
When hypercapnia was established, HR and MAP significantly increased from 
baseline in each group (all, P = 0.001). With an infusion of olprinone, in groups 2 
and 3, HR significantly increased and MAP significantly decreased from the values 
obtained uring hypercapnia ( ll, P = 0.001). By administering CO 2 in each group, 
a significant decrease in pH (all, P = 0.001) and a significant increase in PCO 2 (all, 
P = 0.001) were observed. No significant difference in PO 2 was found in any group 
throughout the experiment (Table II). 
DISCUSSION 
Hypercapnia impairs diaphragmatic contractility in vivo 7 and in vitro. 8 Hypercapnic 
depression of diaphragmatic contractility was previously found in pentobarbital- 
anesthetized dogs. 4 Similarly, in this experimental study, Pdi at 20-Hz and 100-Hz 
stimulation significantly decreased from baseline (all, P = 0.001) in the presence of 
hypercapnia (PCO 2 80-90 mm Hg). The mechanism by which hypercapnia reduces 
diaphragmatic contractility remains unclear. However, an alteration of pH might be 
related to a decrease in the affinity of troponin for calcium, an increase in the binding 
of calcium by the sarcoplasmic reticulum, or a reduction in the rate of glycolysis and 
thus a reduction in the rate of adenosine triphosphate r synthesis. 9-1l 
In this experimental study, Pdi at 20-Hz and 100-Hz stimulation increased signifi- 
cantly from hypercapnia-induced values (all, P = 0.001) with an infusion of olprinone 
at doses of 0.1 to 0.5 lag/kg • rain -1. Also, there was a significant correlation between 
olprinone dose and Pdi at both stimuli (all, P = 0.001). Therefore, olprinone increased 
the reduced iaphragmatic contractility produced by hypercapnia n a dose-dependent 
manner in these dogs. The exact mechanism by which olprinone increases diaphrag- 
matic contractility during hypercapnia s unknown. However, it has been suggested 
that olprinone may have a direct positive effect on contractility of the diaphragm. ~i,5 
The potentiating action of olprinone was abolished with nicardipine, a calcium channel 
blocker, in the canine diaphragm) This suggests that olprinone might increase dia- 
phragmatic contractility by influencing calcium transport across the cell membrane. 
No significant changes in Edi-cru (%) or Edi-cost (%) were observed in any group. 
This was in accordance with a previous tudy. 4 These findings suggest hat neither 
hypercapnia nor olprinone (0.1-0.5 1Jg/kg • min -1) administration affects electrical 
activity of the diaphragm. 
246 
Y. F'UJII AND A .  UEMURA 
Table I. Changes in transdiaphragmatic pressure (Pdi) and the integrated electrical 
activity of the diaphragm in pentobarbital-anesthetlzed dogs during baseline, 
hypercapnia, and treatment periods. Data are mean (SD). 
Variable Group Baseline Hypercapnia Treatment 
Pdi, cm H20 
20-Hz stimulation 
IO0-Hz stimulation 
Edi-cru, % 
20-Hz stimulation 
IO0-Hz stimulation 
Edi-cost, % 
20-Hz stimulation 
IO0-Hz stimulation 
1 14.7 (2.2) 13.2 (2.2)* 16.0 (2.2)*~ 
2 15.0 (2.6) 13.3 (2.7)* 22.5 (3.8) *t'r§ 
3 15.1 (1.3) 13.2 (1.2)* 25.2 (l.7)*tt§ll 
4 15.0 (2.1) 13.3 (2.4)* 13.0 (2.1)* 
1 23.0 (3.2) 20.5 (3.2)* 23.0 (2.8) t t  
2 23.1 (2.3) 20.5 (2.3)* 30.0 (3.0)*¢% 
3 23.2 (2.4) 20.7 (2.4)* 34.8 (2.1) *t~'§l/ 
4 23.0 (3.2) 20.6 (2.8)* 20.7 (2.0)* 
1 100.0 (0.0) 98.6 (3.2) 98.6 (3.2) 
2 100.0 (0.0) 98.5 (3.6) 98.5 (3.6) 
3 100.0 (0.0) 98.3 (1.6) 99.1 (2.0) 
4 100.0 (0.0) 98.6 (3.2) 98.6 (3.2) 
1 100.0 (0.0) 99.5 (1.2) 99.5 (1.2) 
2 100.0 (0.0) 99.3 (1.6) 99.3 (1.6) 
3 100.0 (0.0) 99.3 (1.6) 99.3 (1.6) 
4 100.0 (0.0) 99.3 (1.6) 99.3 (1.6) 
1 100.0 (0.0) 99.2 (4.9) 99.2 (4.9) 
2 100.0 (0.0) 99.2 (4.1) 99.2 (4.1) 
3 100.0 (0.0) 99.1 (2.0) 100.0 (3.1) 
4 100.0 (0.0) 99.1 (2.0) 99.1 (2.0) 
1 100.0 (0.0) 99.3 (1.6) 101.0 (1.9) 
2 100.0 (0.0) 99.5 (1.2) 99.5 (1.2) 
3 100.0 (0.0) 99.4 (1.8) 99.4 (1.8) 
4 100.0 (0.0) 99.3 (1.6) 99.3 (1.6) 
Group 1 = olprinone 0.1 pp:~/kg • min-1; group 2 = olprinone 0.3 p~kg • min-1; group 3 = olprinone 
0.5 pg/kg • min-1; group 4 = no study drug; Edi-cru = integrated electrical activity of the crural portion 
of the diaphragm; Edi-cost = integrated electrical activity of the costal portion of the diaphragm. 
• P = 0.001 versus baseline. 
t p = 0.001 versus hypercapnia. 
P < 0.05 versus group 4. 
§ P < 0.05 versus group 1. 
rl p < 0.05 versus group 2. 
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Figure. Relationship between olprinone dose and transdiaphragmatic pressure (Pdi) at 
(A) 20-Hz stimulation and (B) lO0-Hz stimulation in pentobarbltal-anesthetized 
dogs (N -- 24). 
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Table II. Changes in hemodynamics and arterial blood gas values In pentobarbital- 
anesthetized dogs during baseline, hypercapnla, and treatment periods. All 
values are mean (SD). 
Variable Group Baseline Hypercapnia Treatment 
Hemodynamics 
HR, beats/min 
MAP, mm Hg 
Arterial gas values 
pH 
PC02, mm Hg 
P02, mm Hg 
1 139 (5) 148 (5)* 152 (5)* 
2 140 (5) 149 (4)* 159 (5) *t'r§ 
3 139 (6) 148 (4)* 165 (4) *t% 
4 138 (6) 147 (7)* 147 (5)* 
1 120 (7) 130 (7)* 126 (7)* 
2 122 (5) 131 (5)* 120 (5) *t'r§ 
3 121 (8) 129 (8)* 115 (7) *t% 
4 121 (7) 130 (6)* 131 (6)* 
1 7.42 (0.01) 7.14 (0.01)* 7.15 (0.01)* 
2 7.40 (0.01) 7.13 (0.01)* 7.14 (0.01)* 
3 7.41 (0.01) 7.13 (0.01)* 7.14 (0.01)* 
4 7.39 (0.01) 7.13 (0.01)* 7.14 (0.01)* 
1 37.6 (1.3) 86.0 (4.2)* 86.0 (2.2)* 
2 37.0 (1.5) 86.1 (3.0)* 85.8 (2.3)* 
3 37.6 (2.0) 85.8 (3.0)* 85.5 (3.3)* 
4 37.0 (1.7) 85.8 (2.7)* 85.8 (2.1)* 
1 150.0 (2.1) 149.3 (2.3) 149.5 (1.9) 
2 149.8 (3.6) 148.1 (6.0) 150.1 (6.5) 
3 150.2 (4.0) 150.0 (5.2) 151.3 (6.9) 
4 150.6 (1.6) 150.3 (2.6) 150.8 (2.6) 
Group 1 = olprinone 0.1 pg/kg • min-1; group 2 = olprinone 0.3 pg/kg • min-1; group 3 = olprinone 
0.5 pg/kg • min-1; group 4 = no study drug; HR = heart rate; MAP = mean arterial pressure; PCO 2 = partial 
pressure of carbon dioxide in arterial blood; PO 2 = partial pressure of oxygen in arterial blood. 
• P = 0.001 versus baseline. 
• P = 0.001 versus hypercapnia. 
~'P < 0.05 versus group 1. 
§P < 0.05 versus group 4. 
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Tachycardia nd hypertension are signs of CO 2 retention. 12When hypercapnia was 
established, HR and MAP increased significantly from baseline (all, P = 0.001). These 
hemodynamic changes are similar to those described previously. 4 
The improvement in hypercapnic depression of diaphragmatic contractility asso- 
ciated with olprinone administration must be considered within the context of the 
study limitations. First, the control group (group 4) did not receive saline. However, 
in a preliminary experiment, 4 placebo (saline) was not found to affect diaphrag- 
matic muscle function in pentobarbital-anesthetized dogs. Second, diaphragmatic 
contractility was assessed using the maximal Pdi generated by test stimuli, instead 
of the measurement of mean Pdi. This was the same measurement described previ- 
ously. 4,5 Third, the mechanism by which olprinone improves hypercapnic depression 
of diaphragmatic contractility was not studied. Although the mechanism remains 
unknown, our findings might have important potential therapeutic mplications for 
diaphragm muscle dysfunction during hypercapnia. Future studies should consider 
these limitations. 
CONCLUSION 
Olprinone was associated with improvement, in a dose-dependent manner, of hypercapnia- 
induced impairment of diaphragmatic contractility in these pentobarbital-anesthetized 
dogs. 
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